Compare CAAS & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAAS | OPRX |
|---|---|---|
| Founded | N/A | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Business Services |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.6M | 115.4M |
| IPO Year | N/A | 2008 |
| Metric | CAAS | OPRX |
|---|---|---|
| Price | $4.15 | $6.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 27.5K | ★ 533.6K |
| Earning Date | 05-13-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.49 |
| P/E Ratio | ★ $3.97 | $23.93 |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $3.50 | $5.54 |
| 52 Week High | $5.15 | $22.25 |
| Indicator | CAAS | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 38.64 |
| Support Level | $4.12 | $5.74 |
| Resistance Level | $4.40 | $14.11 |
| Average True Range (ATR) | 0.13 | 0.45 |
| MACD | 0.00 | 0.15 |
| Stochastic Oscillator | 36.36 | 22.84 |
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.